HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enterobacter endophthalmitis: Clinical settings, susceptibility profile, and management outcomes across two decades.

AbstractPurpose:
To describe the clinical presentation and management of Enterobacter endophthalmitis and compare with previous in-house published literature.
Methods:
This was a retrospective interventional comparative case series involving 44 cases with culture proven Enterobacter endophthalmitis from April 2006 to August 2018 who underwent vitrectomy/vitreous biopsy, intravitreal antibiotics with or without additional procedures as appropriate. The current outcomes were compared to the outcomes previously reported a decade back from our center. The mean age at presentation, predisposing factor, number of interventions, interval between inciting event and presentation, type of intravitreal antibiotic used, anatomic, and the functional outcomes were analyzed and compared to the previous series.
Results:
There were 30 males. Mean age was 22.73 ± 21.35 years (median 14 years). Inciting event was open globe injury in 34 (77.27%) eyes, 4 (9.09%) eyes following cataract surgery, 3 (6.81%) eyes with endogenous endophthalmitis, 2 (4.54%) eyes following keratoplasty, and 1 eye (2.27%) following trabeculectomy. Presenting visual acuity was favorable (≥20/400) in 2 eyes (4.54%), at the final visit it was in 11 eyes (25%). The organisms were most sensitive to ciprofloxacin (95.12%), amikacin (90.47%), and ceftazidime (85.36%). A comparison of the current study with previous in-house study showed that number of eyes with presenting vision ≥20/400 as well as final vision ≥20/400 were comparable. Susceptibility was highest to ciprofloxacin 39 (95.12%) (previous series) and 33 (92%) (current series).
Conclusion:
Enterobacter organisms show susceptibility to ciprofloxacin, amikacin, and ceftazidime. Susceptibility profile, clinical presentations, and management remain largely similar over many years. Final outcome is unfavorable.
AuthorsVivek Pravin Dave, Avinash Pathengay, Shashwat Behera, Joveeta Joseph, Savitri Sharma, Rajeev Reddy Pappuru, Taraprasad Das
JournalIndian journal of ophthalmology (Indian J Ophthalmol) Vol. 68 Issue 1 Pg. 112-117 (01 2020) ISSN: 1998-3689 [Electronic] India
PMID31856484 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
Topics
  • Anti-Bacterial Agents (therapeutic use)
  • Endophthalmitis (diagnosis, drug therapy, microbiology)
  • Enterobacter (isolation & purification)
  • Enterobacteriaceae Infections (diagnosis, drug therapy, microbiology)
  • Eye Infections, Bacterial (diagnosis, drug therapy, microbiology)
  • Female
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Retrospective Studies
  • Visual Acuity
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: